Abstract: The inappropriate use of antimicrobials has resulted in the selection of resistant strains. Thus, a great number of studies have focused on the investigation of new antimicrobial agents. The use of zinc oxide nanoparticles (ZnO NPs) to optimise the fight against microbial resistance has been receiving increased attention due to the non-specific activity of inorganic antimicrobial agents. The small particle size and the high surface area of ZnO NPs can enhance antimicrobial activity, causing an improvement in surface reactivity. In addition, surface modifiers covering ZnO NPs can play a role in mediating antimicrobial activity since the surface properties of nanomaterials alter their interactions with cells; this may interfere with the antimicrobial effect of ZnO NPs. The possibility of using surface modifiers with groups toxic to microorganisms can improve the antimicrobial activity of ZnO NPs. Understanding the exact toxicity mechanisms is crucial to elucidating the antimicrobial activity of ZnO NPs in bacteria and fungi. Therefore, this review aims to describe the mechanisms of ZnO NPs toxicity against fungi and bacteria and how the different structural and physical-chemical characteristics of ZnO NPs can interfere in their antimicrobial activity.
Introduction
The inappropriate use of antimicrobials has resulted in the emergence of multidrugresistant strains, causing an increase in infectious disease and mortality.
1,2 Bacterial resistance may be generated by genetic mutations arising from adaptive responses or via horizontal gene transfer (HGT). 3 HGT can occur by conjugation, which requires cell-cell contact across the cell surface pili or adhesins (elements present in the cellular structure of some bacteria), through which the DNA is transferred by plasmids from the donor cell to the recipient cell. For example, β-lactamases have been found to be transmitted by plasmids and are capable of being transferred between bacterial species. 4 In the same way, the prolonged and intense use of antifungal compounds has led to decreased sensitivity and increased numbers of strains resistant to miconazole, fluconazole and amphotericin-B. These drugs are still considered the best standards for the treatment of severe mycoses, but severe adverse effects such as chronic toxicity limit the use of these drugs due to renal function impairment. 5 Another important resistance mechanism is biofilm production. Biofilms are found adhered to a solid surface and are composed of an array that covers a community of bacterial cells and protects them from the action of antibiotics.
Commonly used antimicrobials act by inhibiting essential components to maintain microbial metabolism, such as cell wall synthesis (beta-lactams, glycopeptides), proteins (aminoglycosides, macrolides, chloramphenicol), DNA (quinolones, coumarins), RNA (rifamycins) and intermediate metabolism (sulphonamides and trimetropine). 7 However, one of the main challenges of biomedical researchers is to develop antibacterial drugs that are able to combat biofilm-forming and multidrug-resistant strains. Based on this problem, the use of nanomaterials as antimicrobial agents is justified. This is because the areas in which antibiotics fail can be filled by using nanomaterials in a number of ways: overcoming the mechanisms of microbial resistance through membrane disruption or impeding biofilm formation, or stopping microbial growth using multiple mechanisms of action simultaneously. This is due to the fact that most antibiotic resistance mechanisms do not correspond to the same pathways in which nanomaterials act. 8 In this sense, the use of inorganic nanoparticles can be an alternative to minimise microbial resistance and to reduce toxicity to human cells. 9 Recent advances in nanotechnology have enabled the production of particles with various sizes, shapes and a large surface area relative to volume, allowing for interactions with bacterial cells. This has led to the development of new biocidal agents. 10 Zinc oxide (ZnO), titanium dioxide and silver are used in different areas to control microbial growth. 11 However, ZnO has greater advantages because it has the highest photocatalytic efficiency among all the inorganic photocatalytic materials and is more biocompatible than titanium dioxide. Additionally, ZnO has greater selectivity, better durability and heat resistance, it can be used to combat a diversity of microorganisms, such as S. aureus, 9,12,13 E. coli 14 and C. albicans. [15] [16] [17] ZnO is a semi-conductor presenting a high bandgap of 3.4 eV and binding energy of 60 meV, leading to peculiar electrical and optical properties. [18] [19] [20] As an antimicrobial agent, ZnO has been investigated on the microscale and nanoscale. 17 A decrease in ZnO particle size causes changes in the electrical, optical and chemical properties; some authors believe that these changes are caused by the quantum confinement surface, thus enabling new applications. 21 For instance, when the size of ZnO is reduced to the nanoscale, its activity against microorganisms is increased. 17 Particularly in terms of antimicrobial applications, among the advantages of using an inorganic material rather than an organic material are reduced toxicity, improved durability, lower resistance and good selectivity. 2, 22 Recent studies have demonstrated that ZnO NPs are efficient at combating multidrug-resistant bacteria 23 and preventing biofilm formation. 24 The mechanism of ZnO NP toxicity depends on the modification of the surface, the intrinsic physicochemical properties of ZnO and the medium used to disperse the NPs. Several studies have investigated the mechanisms of action of ZnO NPs on bacteria and fungi, but these studies have not been conclusive. 12, [25] [26] [27] [28] As previously mentioned, the use of ZnO NPs may be a promising alternative to minimising microbial resistance. In addition, it is possible to produce ZnO NPs with various sizes, shapes and surface modifications. Therefore, this review aims to summarise the mechanisms of action described in the literature and how the physicochemical properties and surface modifications of ZnO may alter their antimicrobial activity. Thus, this review may help to clarify the most desirable ZnO NP characteristics to achieve the optimal antimicrobial effect.
Mechanism Of Antibacterial Activity Of ZnO NPs
To better understand how the structural parameters of ZnO NPs could alter their antimicrobial activity, this section will describe the main mechanisms of action found in the literature. It is important to highlight that many studies have addressed this theme. However, as nanoparticles act in a non-specific manner, more than one mechanism may explain their activity, which makes the interpretation of the main mechanism responsible for antimicrobial activity more difficult.
ZnO aqueous suspensions allow for chemical interactions between hydrogen peroxide and the proteins of the cell membrane. Thus, the different chemical species formed explain the different antimicrobial activities. 29, 30 The proposed mechanisms are (i) the production of reactive oxygen species (ROS); 2, 12, [29] [30] [31] (ii) the loss of cellular integrity following contact between ZnO NPs and the cell wall; 32, 33 The ROS production mechanisms driven by ZnO NPs are described in Figure 1 . As a semiconductor, the electronic structure of the ZnO consists of a conduction band Raghupathi and co-workers 12 attributed the increased antibacterial activity of ZnO NPs with increased ROS production by NPs after exposure to UV light. However, some studies have shown that ROS can be created even without light exposure. 37, 38 Hirota et al 38 developed ZnO ceramics with sustainable antibacterial activity. The analyses of electron spin resonance and chemical photoluminescence showed that the antibacterial activity of ZnO could be attributed to superoxide anion production on the ZnO surface, even under dark conditions. The bacterial cell wall has negative charges, like hydroxyl radicals and superoxides, so they cannot penetrate the membrane, but direct contact can cause damage. Therefore, these species can be found only outside the bacterium. Conversely, hydrogen peroxide is able to pass through the cell wall and can be internalised in the bacterial cell, triggering cell death. 2, 31, 33 D'Água et al 39 showed that bacteria that were more sensitive to hydrogen peroxide were also the more sensitive to ZnO NPs. Similar results were obtained with less sensitive bacteria. In this way, the authors suggested that peroxide hydrogen could be the mechanism responsible for the antibacterial activity of ZnO NPs. Kadiyala et al 40 recently studied the antibacterial mechanism of ZnO NPs against methicillin-resistant S. aureus. Contrary to studies demonstrating that the antimicrobial activity is dependent on the ROS or Zn ions, in this study, ROS toxicity was not the principal mediator of antibacterial activity. The most relevant parameters to explain the activity of ZnO NPs were mechanisms that involved pyrimidine, sugar metabolism and amino acid biosynthesis. Another mechanism that may be responsible for damage to microorganisms is photoconductivity, which is a process of photo-induction. 36 Due to its semiconductor properties, ZnO has high photocatalytic efficiency; this can contribute to its antimicrobial effect. 17, 31 Therefore, when
ZnO is submitted to UV light, the antimicrobial effect can be optimised due to the improvement in conductivity, which activates the interactions between ZnO and bacterial cells. Moreover, when the UV light is turned off, conductivity persists. 35 The release of free ions by various NPs was studied, including ZnO NPs. For this purpose, they used strains of E. coli, B. subtilis and S. aureus. The maximum fraction of metal ions that can be released by NPs was used in the experiment. At a concentration of 125 mg/mL of ZnO NPs, 6.8 mg/mL of zinc ions were released; thus, the bacteria were placed in contact with the ions and the antibacterial activity was assessed. The results showed that, in the evaluation of free ion activity, inhibition was low (from 2% to 3% for all strains tested), but the ZnO NPs showed high toxicity for all strains tested. Thus, the authors suggested that NPs activity may be related to intrinsic metal particle toxicity. Another possible toxicity mechanism of ZnO NPs corresponds to the interaction of the ZnO particle with the cell wall, resulting in the loss of bacterial integrity. 16 Possible mechanisms of the antifungal activity of ZnO NPs are also described in the literature. ZnO NPs may enter the cell by diffusion and endocytosis; once in contact with the cytoplasm, they interfere in the functioning of mitochondria, promoting the release of ROS and Zn 2+ .
These released ions can penetrate the membrane and reach the DNA, causing nuclear damage like irreversible chromosome damage, which induces cell death. 28 He et al 45 studied the antifungal activity and ZnO NPs against B. cinerea and P. expansum. Scanning electron microscopy (SEM) and Raman spectroscopy were used to assess morphological changes and cellular composition of hyphae after treatment with ZnO NPs. Inhibition of the both fungi was achieved; however, P. expansum was more sensitive. For B. cinerea, hyphae malformation was observed, suggesting inhibition by affecting cell function and causing increased nucleic acids derived from the hyphae in response to oxidative stress. In contrast, ZnO NPs inhibited the development of conidiophores and conidia of P. expansum. These differences in susceptibility may have been caused by the inherent tolerance of each fungus or differences in morphological growth. Indeed, P. expansum grows more densely on the surface of the agar, leading to better exposure to ZnO NPs. Lipovsky et al 46 studied the antifungal activity of ZnO NPs mediated by ROS against Candida albicans. Histidine removes oxygen radicals, and therefore it was added into the culture of C. albicans in order to assess the inhibitory effect on toxicity mediated by ZnO NPs. The results showed that 5 nM histidine inhibited the antifungal effect of ZnO. Thus, the authors suggested that the release of ROS in aqueous media may be responsible for cell death. In addition, in contact with visible light, ZnO NPs provoked an increase in the cell death rate. It has been found that the antimicrobial activity of ZnO NPs is proportional to the NPs concentration; 14, 15, 28 moreover, the level of ROS released by ZnO NPs is also dose-dependent. 28 Pasquet et al 26 suggested that the antimicrobial activity of ZnO NPs in fungi may be lower when compared to bacteria since the fungus has the ability to develop pores in hostile conditions. ZnO demonstrated only fungistatic activity at all NPs concentration used and it did not decrease the initial population. In contrast, a study performed by Eskandari et al 47 showed that ZnO nanorods not only decrease the growth of C. albicans but also have fungicidal activity. ZnO NPs have Gram-positive and Gram-negative antibacterial activity and antifungal activity; 48 however, the strength of the effect depends on the sensitivity of the microorganism. 49 A study performed by Shinde et al 50 on
the antimicrobial activity of ZnO microspheres (MS-ZnO) against S. aureus and E. coli suggested that the difference in susceptibility of MS-ZnO in the two bacteria may be explained by the differences in their cell wall. The cell wall of Gram-positive bacteria consists of a thick layer of peptidoglycan (20-80 nm), which provides a physical barrier that serves to protect the environment of the cell. This thick layer of peptidoglycan also is responsible for fixing polymers such as teichoic and lipoteichoic acids and surface proteins. 49, 51 Gram-negative bacteria have a cell wall with a complex organisation. There is a thin peptidoglycan layer and an external membrane that contain lipopolysaccharides. The external membrane and peptidoglycan are linked by lipoproteins. The peptidoglycan layer is located in the periplasmic space that is formed between the external membrane and the cytoplasmic membrane. 25, 32, 52 The cell wall is responsible for maintaining the osmotic pressure and the shape of the cell. NPs of various sizes can easily pass through the layer of peptidoglycan and therefore are highly capable of causing damage. 17 The peptidoglycan layer contains repeated units of amino acids and carbohydrates. Thus, ZnO NPs can interact with carboxylic acid and amino groups and thereby inhibit cellular processes. However, the peptidoglycan layer of Gram-negative bacteria is thinner than the membrane of Gram-positive bacteria, so rupture of the cell membrane is easier. 50 The difference between the components of Gram-positive and Gram-negative cell walls was elucidated in a study conducted by Tayel and co-workers. 53 These researchers suggested that Gram-positive bacteria are more susceptible to attack by ZnO NPs than Gram-negative bacteria. The minimum inhibitory concentration (MIC) of ZnO NPs observed by Reddy et al 54 in S. aureus, a Gram-positive bacterium, and E. coli, a Gram-negative bacterium, was 1 mg/mL and 3.4 mg/mL, respectively, which shows that the inhibition of Gram-negative bacteria requires higher concentrations of ZnO NPs. This is likely because the peptidoglycan layer that surrounds Gram-positive bacteria can promote ZnO attack inside the cell, while the cell wall components of Gram-negative bacteria, such as lipopolysaccharides, can counter this attack. Similar results were found by d'Agua et al, 39 using the agar diffusion method to evaluate the antibacterial activity of textiles containing ZnO NPs. In this study, the authors showed that Gram-positive bacteria were more sensitive to peroxide hydrogen than Gram-negative bacteria. Bacteria present the intrinsic ability to produce some substances that induce resistance to oxidative stress. Sphaphyloxantin is a carotenoid produced by the membrane of S. aureus that functions as an antioxidant. Thus, DNA, proteins and lipids are better protected against oxidative stress due to the presence of sphaphyloxantin. 55 Cytochrome oxidase is an enzyme present in some bacteria that can interfere in the antibacterial activity of ZnO NPs because it directly reduces the amount of oxygen present in the water. In the absence of cytochrome oxidase, oxygen reduction makes use of catalase, which involves more stages. This discussion was approached by Pasquet et al, 26 who observed better activity of ZnO NPs in E. coli than P. aeruginosa, which possesses both cytochrome oxidase and catalase whereas E. coli possesses only catalase. Thus, E. coli catalase is involved in oxygen reduction in water whereas P. aeruginosa catalase is readily available for H 2 O 2 reduction because it is supplemented by cytochrome oxidase. The bacterial growth rate is another factor that can change the bacterial tolerance to ZnO NPs. Bacteria with a slow growth are less susceptible to the action of antibiotics compared to those with rapid growth.
difficult to elucidate all the ways in which ZnO NPs act on bacteria and fungi. According to the literature review on this topic, it is suggested that ROS production may be responsible for most of the toxicity. However, it is important to emphasise that studies have shown new mechanisms, as demonstrated by Kadiyala et al 40 and Tiwari et al. 23 The Influence Of The Physicochemical Parameters Of ZnO NPs On Their Antimicrobial Activity
This section covers the structural parameters that may influence the antimicrobial activity of ZnO NPs, focussing on the relationship between the morphology and size of nanoparticles with antimicrobial activity. The control of these parameters is important because the antimicrobial activity of ZnO NPs depends on their intrinsic physicochemical properties. Thus, the toxicity of ZnO NPs can be altered depending on their morphology and size. Based on these properties, some studies have assessed the impact of the morphology and size of ZnO NPs on their antimicrobial activities. 57, 58 The morphology control of the ZnO NPs is one of the most important factors for their production; therefore, the reaction parameters should be standardised to ensure the shape and size of the product. 50 Stanković et al 58 studied the influence of ZnO NPs shape when synthesised by the hydrothermal method using different types of stabilising agents on the antibacterial activity of ZnO NPs against E. coli and S. aureus. The shape of the particles was investigated by field emission scanning electron microscopy FE SEM that showed hexagonal prisms 1 nm in length and 100 nm in diameter, ellipses with a length of 500-600 nm and a diameter of 100 nm and spherical particles with diameters around 30 nm. ZnO crystal growth depends on the type of the stabilising agent used in the synthesis. Better antibacterial activity was observed with spherical particles synthesised with polyvinyl alcohol (PVA), which presented a larger surface area and smaller size of 30 m 2 .g −1 and 25.70 nm, respectively. In addition, they observed different morphologies for powders prepared with polyvinyl pyrrolidone (PVP) and poly (L-glutamic acid; PGA) presenting greater than 100% differences in surface area. This feature led to different antibacterial activity in S. aureus and E. coli. ZnO powers exhibited almost the same level of antibacterial activity for E. coli, while in the case of S. aureus, the functional dependence was more strongly related to the value of the surface area measurements. This occurred NPs in C. albicans, A. brasiliensis, E. coli, P. aeruginosa and S. aureus. The challenge test was used in this study to assess the relationship between antimicrobial activity and the structural parameters of ZnO NPs. Three samples of ZnO NPs were characterised in terms of crystal size, surface area, porosity and aggregated particles in aqueous medium and in MullerHinton broth. The antimicrobial activity was evaluated by disc diffusion and MIC measurements with the NPs for each microorganism tested. The results showed that the best activity was observed for smaller ZnO crystals and the antimicrobial activity was dependent on the surface area. The photocatalytic effect was more dependent on the crystallinity than the specific area. The size of the agglomerates was not a relevant parameter, because smaller sizes were obtained and resulted in lower activities against the strains tested. However, the formation of agglomerates should be avoided, in order to minimise sedimentation and to maintain the homogeneity of the suspension. Thus, these authors concluded that the most important parameters to explain antimicrobial activity are a small crystal size and high porosity with large pores. Raghupathi et al 12 studied the effect of particle size of ZnO in terms of antibacterial activity. The results showed that the viability of the cell significantly decreased with decreasing particle size (from 212 nm to 12 nm). When the particle size was larger than 100 nm, the inhibition of methicillin-sensitive S. aureus was incomplete. In this case, ZnO NPs had a bacteriostatic function. The particles smaller than 12 nm inhibited not only growth but also killed S. aureus. The results of confocal microscopy showed that the treatment of bacteria with small-sized NPs led to an increase in cell death, probably due to rupture of the bacterial cell wall. Padmavathy and Vijayaraghavan 2 studied the antibacterial activity of ZnO NPs synthesised by two routes that resulted in different particle sizes; therefore, these researchers correlated the influence of NPs size with antibacterial activity. Disk diffusion assays showed that the inhibition zone was increased with smaller sized NPs, which may be related to the ability of these particles to rupture the bacterial membrane. The MIC and MBC assays were performed using E. coli. At concentrations below 1 mM, no significant antibacterial activity was observed in any sample, with 1 mM ZnO NPs, the activity was bacteriostatic, and concentrations of 5-100 mM were bactericidal. The bactericidal activity found at high and low concentrations was better for a suspension of 12 nm ZnO than for 45 nm and 2 µm NPs. hexagonal faceted ZnO quantum dots (Qdots) showed that the photocatalytic activity could be explained in three ways. These results could be also applied to the antimicrobial properties. Because ZnO Qdots are very small nanoparticles, they have a high specific surface area, which enables more contact with the microorganism surface. Another reason is related to the hexagonal faceted morphology. Due to its unsaturated oxygen coordination and positive charge, the (001) face is able to adsorb oxygen molecules and OH − ions. This results in a higher rate of H 2 O 2 and OH• radical production, and hence increased antimicrobial activity. Table 1 provides a summary of the different studies used in this review and the main conclusions. As we can see, the most relevant parameter for excellent activity was the small size of the NPs. It was found that ZnO NPs with a smaller size are found at a higher concentration in the blood than larger ones (19 and >100 nm). 63 In the same way, the better activity of smaller sized NPs may be attributed the need for more smaller particles to cover the bacterial colony, which results in the generation of higher concentrations of ROS released 67 who dispersed ZnO NPs in an ionic liquid. This enhanced the bactericidal efficacy against S. epidermidis because ZnO NPs in ionic liquids showed elevated production of ROS. In addition to surface modifications used to improve stability as mentioned earlier, it is possible to design systems in which the surface of ZnO NPs is altered in order to optimise their antimicrobial activity. For example, this can be done using organosilanes. Organosilanes can be formed by different organic functional groups and are precursors of corresponding organosilanols or organosilsesquioxanes. They are inorganic-organic hybrid materials that can be applied to different substances to modify their surface by attaching oxides by silyation. 68 Thus, for the stabilisation of ZnO NPs, researchers have modified their surface with organosilanes, because these molecules bind covalently to the hydroxylated surface of NPs, making them stable in water by creating a barrier that protects the NPs in the nucleus and allows the dispersion of NPs in water. 69, 70 The surface topography of a material can change bacterial behaviour. This occurs because surface properties affect cellular adhesion and influence cellular metabolism. 71 A study conducted by Jana et al 72 showed that αFe 2 O 3 -ZnO nanocomposites in the nanoscale and microscale had differences in terms of the roughness of the surface morphology. Thus, it was concluded that surface roughness is very important for antibacterial activity. The surface properties of nanomaterials alter interactions with the cell and can interfere with the antimicrobial effect of ZnO NPs. 49 Doping of metal oxides is one strategy to improve their photocatalytic properties and can result in changes to the surface area due to the introduction of dopant ions. Thus, the presence of impurities in semiconductor NPs can lead to dramatic changes in their structural, electrical and optical properties. The introduction of dopants during the nanostructure formation process will cause new crystal growth conditions, inducing drastic changes in internal defects and morphology. [73] [74] [75] In these defects, enhanced oxygen vacancy favours photocatalytic reactions, and therefore a higher amount of ROS is produced.
76,77
The presence of dopant ions in ZnO NPs has been used in some studies to assess their relationships with the antimicrobial activity of ZnO NPs. 61, 78 The presence of these dopant ions can change the size of ZnO NPs. 79 This characteristic is important for the antimicrobial effect of NPs. In addition, higher ROS concentrations result in greater antimicrobial activity by ZnO NPs; ROS generation is a major mechanism responsible for ZnO NPs antimicrobial activity. The abovementioned toxicity mechanisms, such as the production of oxygen radicals, Zn 2+ ions and the interaction of ZnO NPs with the cell membrane, are affected by surface coatings, 80 and these surface characteristics may help in interactions between NPs and the cell wall of bacteria and fungi. 81 Based on the relevant information presented in this section, the next items will be discussed in order to show the influence of antimicrobial activity obtained with the introduction of dopants or surface modifiers (with a focus on organosilanes) in ZnO NPs. The discussion about these parameters is very important because ZnO NPs structural changes result in new properties that can enhance the antimicrobial activity of ZnO NPs. Understanding how doping and surface modifications alter the properties of ZnO NPs is already a challenge. However, applying these findings to antimicrobial activity may be an excellent alternative to achieve ZnO NPs-based systems with excellent antimicrobial properties. showed that there were significant differences in the MIC values for undoped and doped NPs. Better antimicrobial activity was obtained with 10% dopant than for 1% doped and undoped NPs. Synergistic interactions were observed with Cip and Amp for NPs with 10% dopant. For fungi, only an additive effect was found with Flu and Amp B. The presence of dopants can accelerate ROS formation due to the synergistic effect of Mn, Cu, Co and Fe, which improve the photocatalytic activity of ZnO NPs. Based on this improvement in the activity of ciprofloxacin when associated with ZnO NPs, some researchers assumed that ZnO NPs may interfere with the pumping activity of NorA protein in S. aureus. NorA protein mediates hydrophilic fluoroquinolone efflux to the cell, conferring resistance to the microorganism. Recent reports have suggested that metallic oxide NPs are able to induce faster transfer of electrons to the active sites of enzymes, so ZnO NPs could interfere with the pumping activity of this protein (overexpression of the protein is related to cases of microbial resistance to the action of fluoroquinolones in S. aureus and E. coli). 61, [82] [83] [84] Another explication can be attributed to ZnO NPs relationship with the increased absorption of antibiotics in S. aureus cells, which is mediated by the Omf protein (responsible for the permeation of quinolones through the cell membrane). 61, 82, 85 Some antibiotics are able to form complexes with metal ions, such as Co, Ni and Cu, as shown by Patel et al, who demonstrated the ability of ciprofloxacin to form a complex with chelating agents. In this way, it is possible that the fluorine atom reacts with the Zn atom, stabilising the combination of Cip-ZnO. 86 Ravichandran et al 87 doped ZnO NPs with Cu and graphene. No change in antibacterial activity was observed with ZnO:Cu. It is important to highlight that the concentration of Cu (less than 1%) was less than that in the studies conducted by Sharma et al. 61 Thus, differences in the concentration of a dopant can result in different activities. rare earth elements such as cerium (Ce), lanthanum (La) and gadolinium (Gd). There was an increase in ROS achieved by Ce-La dual-doped ZnO NPs compared to NOP doped with the other ions. However, the particle size of this sample was smaller than the other doped ZnO NPs. Additionally, Ce-La ZnO NPs had more lattice defects and higher photocatalytic efficiency. Thus, the researchers attributed these characteristics to the enhancement of antibacterial activity. ZnO NPs were dual doped with Sn and Cu by Vignesh et al. 92 The results showed that dual-doped ZnO NPs induced larger zones of inhibition in antibacterial assays than pure ZnO and Sn:ZnO and Cu:ZnO. The authors suggested that, although the antibacterial activity was attributed the higher amount of ROS produced by dual doped ZnO NPs and the deposition of NPs on the surface of the bacteria, a decrease in crystallite size was also one of the reasons for the enhanced antibacterial activity.
Doped ZnO NPs
In this section, we showed that doping ZnO NPs may be one way to enhance antibacterial properties due to increases in oxygen vacancies and ROS production. However, not all doping strategies resulted in better activity, even when using the same dopant. This shows that the improvement of activity does not depend solely on the dopant but also on the structural characteristics of ZnO NPs. Therefore, it is important to control the reaction in order to produce doped nanoparticles with large quantities of oxygen vacancies and with small sizes. Doped ZnO NPs with small sizes showed the best antibacterial activity. In addition to silanes, ZnO NPs are associated with other compounds to achieve optimised antibacterial activity. In studies performed by Sehmi et al, 90 it was demonstrated that oleate-capped ZnO NPs combined with crystal violet were biocompatible and significantly reduced the numbers of S. aureus, possibly due to the oleate ligand itself. Additionally, ZnO capped with di(octyl)phosphinic acid (DOPA) showed excellent antibacterial activity against E. coli without a photosensitiser or white-light activation. However, regarding antibacterial activity against strains of methicillin-resistant S. aureus (MRSA), better antibacterial activity was obtained with ZnO NPs prepared with crystal violet and DOPA. The smaller size of the ZnO-DOPA NPs (∼2-4 nm) compared to that of ZnO_OA NPs (∼18 nm) resulted in better antibacterial activity.
Surface Modified ZnO NPs: Focus On Organosilanes
Although there are many methods for modifying the surface of ZnO NPs, the use of organosilanes has become one of the most widely used methods. The major advantage of using silanes is their rapid covalent bond formation, which results in a thin layer on the surface of the ZnO. This covalent bonding is responsible for stabilising the monolayer, making further modification easy without compromising the integrity of the surface film.
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In a study conducted by Soumya et al, 96 it was observed that silane-modified ZnO NPs had a very narrow size distribution with an average particle size of 220 nm. In contrast, without modification, the size distribution was bimodal, and in this case, the particles were in the range of 255-970 nm. The wide size distribution clearly indicated that, in the absence of silane, ZnO nanoaggregates were obtained. In summary, this section has shown that different silanes can be used to modify ZnO NPs. Although there are many strategies for performing ZnO surface modification, the use of silanes has many advantages. In addition to the rapid reaction, there are many silanes on the market that allow nanoparticles to be dispersed in hydrophilic or hydrophobic media, improving their stabilisation. However, the main advantage of using these silanes is the size control of the formed NPs. For example, GPTMS-modified ZnO NPs showed greater resistance to growth when subjected to high temperatures compared to unmodified NPs. 43 This control of nanoparticle growth coupled with a better size distribution results in a system with better antimicrobial properties, enabling the formation of nanoparticles with optimised antimicrobial properties, since obtaining small NPs is one of the requirements for improving antimicrobial activity.
Conclusion
The lack of a standard in relation to the microbial strains used in these studies and the methodologies for microbiological testing are sources of uncertainty. However, in this review, it was possible to see that the most important mechanism to explain the antimicrobial activity of ZnO NPs is ROS production. Some researchers have shown that the different physical and chemical parameters can change the antimicrobial activity of ZnO NPs; the most relevant parameter found in our review regarding antimicrobial activity was the size of ZnO NPs. The importance of size as the most relevant parameter is supported by the same MIC values found in studies performed by different researchers using nanoparticles of the same size. In addition, when studies compared nanoparticles with different morphologies, generally those that were more toxic to microorganisms were also smaller.
The use of dopants can increase the activity of ZnO NPs. As the proportion of dopants increases, NPs tend to decrease in size. In addition, in general, larger amounts of ROS are produced, which results in better activity. Surface modifications of ZnO NPs, in general, lead to improved antimicrobial activity, reducing the MIC of these NPs against the tested microorganisms. This happens due to the improved size distribution and growth resistance of ZnO NPs. These findings once again support the need for nanoparticle size control to achieve optimal antimicrobial activity.
The limitations and future outlook consist of better understanding the antibacterial activity of ZnO NPs, which is a challenge because studies continually reveal new mechanisms, which shows that not all existing mechanisms are understood and there is a need to better explore this area. The lack of a standard in relation to the microbial strains used in these studies and the methodologies for microbiological tests has led to conflicting results. There are many studies on ROS toxicity, but only the intracellular inhibitory mechanisms and protein synthesis, gene expression and metabolism of bacterial cells. Thus, as future perspectives, it is important that further research be conducted in this regard.
